News

Treatment with broad-spectrum antibiotics often leads to side effects, as it affects not only the pathogens but also the “good” bacteria in the gut. A research team from Hannover Medical School (MHH)

The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate

The Incubator for Antimicrobial Therapies in Europe, INCATE, aims to support innovators in the early stages of developing therapies in the field of antimicrobial resistance. The German Center for

Why do the gut microbiomes of people from industrialized and non-industrialized regions differ? A study by the research team led by DZIF scientist Prof. Till Strowig of the Helmholtz Centre for

In acute, life-threatening infections, rapidly characterizing the microorganisms in a patient sample can help guide diagnosis and treatment. This is possible by using computational methods known as

According to the World Health Organization (WHO), tuberculosis (TB) affects more than 10 million people and causes over a million deaths each year, making it one of the world’s deadliest infectious

An international working group led by the German Society for Infectious Diseases (DGI) has developed a guideline for personalized phage therapy. Twenty professional organizations, 18 international

The current outbreak of Bundibugyo virus (BDBV) in the Democratic Republic of the Congo highlights the challenges of responding to rare but potentially devastating infectious diseases. Two studies led

The DZIF flagship project PANTIPA has reached an important milestone. Following successful preclinical work at the University Hospital Cologne and the Helmholtz Centre for Infection Research, the

The SARS-CoV-2 virus is constantly mutating. As a result, vaccines become less effective and require regular adaptation. This was the case in 2025 with the JN.1 variant. An interdisciplinary team from